Claremont, CA, United States of America

Deb Narayan Chakravarti

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Deb Narayan Chakravarti: Pioneering Innovations in Immunogenic Compositions

Introduction

Deb Narayan Chakravarti is an accomplished inventor based in Claremont, CA, with a notable portfolio of two patents. His work primarily focuses on the realm of immunogenic compositions and the newly identified open reading frames that play a critical role in medical biotechnology.

Latest Patents

Chakravarti's latest inventions pertain to open reading frames within genomic nucleotide sequences, which encode polypeptides that are surface localized. These inventions provide significant insights into polypeptide antigens and the development of vectors containing these open reading frame sequences. The implications of his work are far-reaching, involving methods for detecting specific nucleic acids or polypeptides, as well as the creation of diagnostic kits for bacterial infections. Notably, his research emphasizes immunogenic compositions aimed at both systemic and non-systemic diseases, including conditions such as otitis media.

Career Highlights

Throughout his career, Deb Narayan Chakravarti has worked with distinguished organizations, notably Wyeth and Wyeth Holdings Corporation. His responsibilities in these roles have allowed him to contribute significantly to advancements in the field of pharmaceuticals, particularly concerning immunological responses and treatments.

Collaborations

Chakravarti has collaborated with esteemed colleagues in his field, including Robert J. Zagursky and Amy Wadhams Masi. These collaborations have enriched his research and provided broader perspectives on the challenges faced within the realm of immunology and biotechnology.

Conclusion

Deb Narayan Chakravarti stands out as a pivotal figure in the development of immunogenic compositions and related technologies. His innovative approach and substantial contributions to the understanding of polypeptide antigens demonstrate his commitment to advancing medical science and improving healthcare outcomes. As the field continues to evolve, inventors like Chakravarti will undoubtedly play a crucial role in shaping the future of biotechnology and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…